Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.
The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.
Ulisse Biomed is fully committed to supporting the healthcare and medical sectors.
Ulisse Biomed provides a comprehensive range of different diagnostic solutions, with the aim of assessing many threats to human health in real time and minimising the risks associated with the spread of pathogens and subsequent infections through specific infection monitoring protocols.
Determination of POLYMORPHISM -455 G>A OF FGB GENE (fibrinogen)
T1565C GPIIIa POLYMORPHISM (ITGB3 gene)
Determination of T1565C GPIIIa POLYMORPHISM (ITGB3 gene)
Cardiovascular
Name
Description
AGT gene T9543C POLYMORPHISM
Determination of AGT gene T9543C POLYMORPHISM
T3932C POLYMORPHISM (CYS112ARG) APO-E
Determination of T3932C POLYMORPHISM (CYS112ARG) APO-E
C4070T POLYMORPHISM (ARG158CYS) APO-E
Determination of C4070T POLYMORPHISM (ARG158CYS) APO-E
R3500Q MUTATION (R3527Q) APO B-100
Determination of R3500Q MUTATION (R3527Q) APO B-100
POLYMORPHISM A1166C AGTR1
Determination of POLYMORPHISM A1166C AGTR1
MTRR A66G POLYMORPHISM
Determination of MTRR A66G POLYMORPHISM
Hemochromatosis
Name
Description
HFE GENE C282Y MUTATION
Determination of HFE GENE C282Y MUTATION
H63D HFE gene MUTATION
Determination of H63D HFE gene MUTATION
HFE gene S65C MUTATION
Determination of HFE gene S65C MUTATION
R3500Q MUTATION (R3527Q) APO B-100
Determination of R3500Q MUTATION (R3527Q) APO B-100
POLYMORPHISM A1166C AGTR1
Determination of POLYMORPHISM A1166C AGTR1
MTRR A66G POLYMORPHISM
Determination of MTRR A66G POLYMORPHISM
Immuno response
Name
Description
C/T polymorphism of CCR3 gene
Determination of C/T polymorphism of CCR3 gene
POLYMORPHISM G/A gene cluster IL18RAP
Determination of POLYMORPHISM G/A gene cluster IL18RAP
Oncology
Name
Description
POLYMORPHISM -397 T>C ESR1 (dbSNP ID: rs2234693)
Determination of POLYMORPHISM -397 T>C ESR1 (dbSNP ID: rs2234693)
POLYMORPHISM *39 AG ESR2 A1730G (dbSNP ID:rs4986938)
Determination of POLYMORPHISM *39 AG ESR2 A1730G (dbSNP ID:rs4986938)
03
Oncohematology
Myeloproliferative syndromes
Name
Description
JAK2 (Janus kinase 2)
Qualitative and quantitative determination of the V617F mutation of the JAK2 gene(Janus kinase 2)
MPL
Determination of W515L/K mutations in the MPL gene(Mieloproliferative Leukemia Virus Oncogene)
CALR (chaperone calreticulin)
Qualitative determination of INS 5bp/DEL 52bp mutations of exon 9 of the CALR gene(chaperone calreticulin)
Acute and chronic leukemia
Name
Description
BCR-ABL1 t(9;22)
Qualitative determination of the translocation t(9; 22) of BCR-ABL1 and identification of p190 transcripts; p210 and p230 of the endogenous abl gene (Sample Eligibility)
PML-RARA t(15;17) (q22;q21)
Qualitative determination of the translocation t(15; 17) PML-RARA t(9; 22) and identification of the BCR1, BRC2 and BCR3 transcripts of the endogenous ABL gene
AML1-ETO t(8;21) (Q22;Q22)
Qualitative determination of the translocation t(8; 21) AML-ETO and the endogenous gene abl
CBFB-MYH11 INV (16) (p13q22)
Qualitative detection of pericentric inversion INV 16, CBFB-MYH11 and identification of transcripts A, D and E
Oncology
Name
Description
BRAF V600E (T1799A) mutation
Qualitative detection of V600E mutation of the BRAF gene
04
Pharmacogenetics
Metabolism and toxicity of drugs
Name
Description
VARIANTS OF DPYD (DPYD *2A, *13, Asp949Val, 1236 G>A, HapB3 and 2194 G>A, *6)
Detection of genetic variants *2A (rs3918290, 1905 +1G>A, IVS14 +1 G>A), *13 (rs55886062, 1679 T>G), Asp949Val, (rs67376798, 2846 A>T), 1236 G>A (rs 56038477, HapB3) and *6 (2194 G>A, rs 1801160) of the gene DPYD
VARIANTS OF UGT1A1*1 AND UGT1A1*28
Characterization of the genetic variants UGT1A1*1 and UGT1A1*28 of the UGT gene
GSTP1 GENE VARIANT A313G (I105V)
Characterization of the A313G genetic variant of the GSTP1 gene (rs1695)
VARIANTS OF CYTOCHROME P450 CYP2C9 (variants *2 and *3)
Detection of the genetic variants rs1799853 (*2) and rs1057910 (*3) of the CYP2C9 gene
VARIANTS 197 G>T and 19007 T>C OF THE ERCC1 GENE
Determination of the genetic variants 197 G>T (rs3212986) and 19007 T>C (Asn118Asn; NM_001369414.1: c.354T>C, rs11615) of the ERCC1 gene
Pharmacogenetic screening
Name
Description
ABCB1 (MDR1) GENE VARIANT G2677T/A
Detection of genetic variant G2677T; G>T / G2677A; G>A) of the gene ABCB1 (rs2032582)
ABCB1 (MDR1) GENE VARIANT C3435T
Characterization of the C3435T genetic variant of the ABCB1 gene (rs1045642)
ABCB1 (MDR1) GENE VARIANT C1236T
Characterization of the genetic variant C1236T of the ABCB1 gene (rs1128503)
VARIANT ARG399GLN OF THE XRCC1 GENE
Determination of the ARG399GLN polymorphism of the XRCC1 gene (G>A; ARG399GLN; rs25487)
MGMT gene promoter methylation (O6-methylguanine DNA methyltransferase)
Determination of the methylation status of the MGMT (O6-methylguanine DNA methyltransferase) gene promoter by MSP
Impact of Full Vaccination with mRNA BNT162b2 on SARS-CoV-2 Infection: Genomic and Subgenomic Viral RNAs Detection in Nasopharyngeal Swab and Saliva of Health Care Workers
